Martin J. Edelman, MD, has joined Fox Chase Cancer Center as chair of the Department of Hematology/Oncology and deputy cancer center director for clinical research.
Martin J. Edelman, MD
Lung cancer expert Martin J. Edelman, MD, has joined Fox Chase Cancer Center as chair of the Department of Hematology/Oncology. Edelman will also serve as deputy cancer center director for clinical research, leading the effort to integrate discoveries from the Translational Research Initiative into a strong investigator-initiated clinical trials, Fox Chase has announced.
Edelman is currently head of Solid Tumor Oncology and associate director of the Division of Hematology/Oncology at the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC). He will begin his new role effective February 6.
“Dr. Edelman is a visionary in his field, and I am confident he will lead our Department of Hematology/Oncology to even greater heights,” said Richard I. Fisher, MD, president and CEO of Fox Chase. “I am delighted that he has chosen to become a key part of our faculty, and I look forward to what we will all achieve together in the coming years.”
Edelman’s achievements in the field of lung cancer include developing one of the most commonly used regimens for treating advanced lung cancer and working toward the development of new agents and biomarkers to personalize lung cancer therapy.
“Fox Chase Cancer Center has a national and international reputation for excellence,” Edelman said. “I look forward to working with leading experts in cancer research and treatment as we continue the institution’s long legacy of progress against cancer.”
Edelman received his medical degree from Albany Medical College and completed his residency training in internal medicine and a hematology/oncology fellowship at the Naval Hospital in San Diego. He also served for more than 20 years in the United States Navy Reserve, retiring with the rank of Captain.